When More Olive-Oil Phenols Did Not Mean More Plasma Antioxidant Capacity

What the researchers tested

Sidibé and colleagues published the pilot in Clinical Nutrition ESPEN on July 28, 2026. The randomized intervention included 34 older adults, with a mean age of 73.1 years (standard deviation 5.9); 65% were men. Participants were stratified as healthy controls or post-myocardial-infarction participants and assigned to standard extra virgin olive oil, tyrosol/hydroxytyrosol-enriched EVOO, or refined olive oil.

Each person consumed 25 mL per day for 26 weeks. The primary laboratory outcome described in the abstract was plasma Trolox-equivalent antioxidant capacity, or TEAC, measured at baseline and follow-up. Baseline Mediterranean-diet adherence came from three-day food diaries and was classified as low or high.

The publicly indexed abstract does not state the exact phenolic concentration of either EVOO. That missing chemistry matters: this paper cannot be used to assign a mg/kg effect to a retail bottle or to compare the intervention directly with a certificate in our rankings.

The reported results

Within the standard-EVOO group, post-MI participants had a 402 μM greater TEAC increase than healthy controls (95% confidence interval 162 to 641). Also within that standard-EVOO group, participants with high baseline Mediterranean-diet adherence had a 274 μM greater increase than those with low adherence (95% CI 1.6 to 545).

The important counterweight is the abstract's null result: no significant between-group TEAC differences were observed after the enriched-EVOO or refined-oil interventions. The two positive estimates are subgroup comparisons inside the standard-EVOO arm, not proof that standard EVOO prevented cardiovascular events or that enrichment was harmful.

Why dietary context might matter

A food rarely operates in isolation. People with higher Mediterranean-diet adherence may also consume more vegetables, legumes, fruit, nuts and other foods that affect measured antioxidant capacity. Their baseline diet could modify the biological response to EVOO, but it could also leave residual confounding inside a very small subgroup analysis.

Clinical status may matter too. A post-MI participant can begin with a different oxidative-stress profile, medication pattern and capacity for biomarker change than a healthy control. The result is therefore a context signal worth testing, not a reason for anyone with heart disease to self-prescribe olive oil in place of treatment.

Limitations

• • Pilot scale: 34 people split across three oils and two clinical strata leaves small subgroups and imprecise estimates.
• • Surrogate endpoint: TEAC is a plasma laboratory measure, not a clinical event, symptom score or treatment outcome.
• • Subgroup interpretation: the positive estimates compare clinical status and diet adherence within the standard-EVOO group.
• • Incomplete public chemistry: the PubMed abstract does not report the oils' exact phenolic concentrations or the full allocation counts.
• • No dose-response win: the enriched intervention did not show a significant between-group TEAC advantage.
• • Generalizability: the results may not apply to younger adults, other diseases, other oils or ordinary retail use.

Our evidence grade

Interesting but preliminary. Randomization and the 26-week duration are strengths. The sample size, subgroup structure and surrogate outcome keep certainty low. The most defensible conclusion is that plasma antioxidant responses may be context-dependent and were not improved simply by further phenolic enrichment in this pilot.

Primary source

Sidibé H, Morvaridzadeh M, Fülöp T, Berrougui H, Belbraouet S, Nguyen M, Khalil A. Mediterranean diet adherence modulates the plasma antioxidant response to long-term extra virgin olive oil consumption in older adults. Clinical Nutrition ESPEN. 2026; article 103625. doi: 10.1016/j.clnesp.2026.103625.